Compare GRDX & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRDX | CLPS |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United Kingdom | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.2M | 28.3M |
| IPO Year | 2016 | 2017 |
| Metric | GRDX | CLPS |
|---|---|---|
| Price | $3.22 | $0.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 147.2K | 13.6K |
| Earning Date | 11-16-2026 | 10-16-2026 |
| Dividend Yield | N/A | ★ 15.37% |
| EPS Growth | ★ 21.95 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.87 | $0.80 |
| 52 Week High | $6.93 | $1.24 |
| Indicator | GRDX | CLPS |
|---|---|---|
| Relative Strength Index (RSI) | 36.24 | 41.75 |
| Support Level | $3.23 | N/A |
| Resistance Level | $4.19 | $0.99 |
| Average True Range (ATR) | 0.79 | 0.08 |
| MACD | -0.26 | -0.01 |
| Stochastic Oscillator | 26.36 | 15.79 |
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
CLPS Inc is information technology, consulting and solutions service provider, focused on delivering services mainly to world-wide institutions, including banking, wealth management, ecommerce, and automotive areas both in China and globally. It has been at the forefront of driving digital transformation and optimizing operational efficiency across industries through innovations in artificial intelligence (AI), cloud computing, and data. It diverse business lines span sectors including fintech, payment and credit services, e-commerce, education and study abroad programs, and world-wide tourism integrated with transportation services. Its segments are IT services and academic education service. Majority of revenue comes from IT services segment. Its products are NiBot RPA, and CAKU.